Cart
sales@molnova.com
Cisd2 agonist 1
CAS No. 2916371-54-3
Cisd2 agonist 1( —— )
Catalog No. M37138 CAS No. 2916371-54-3
Cisd2 agonist 1 is a potent CDGSH iron-sulfur structural domain 2 (CISD2) agonist (EC50: 34 nM) with potential anticancer activity for the study of non-alcoholic fatty liver disease (NAFLD).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 170 | In Stock |
|
| 5MG | 155 | In Stock |
|
| 10MG | 250 | In Stock |
|
| 25MG | 511 | In Stock |
|
| 50MG | 830 | In Stock |
|
| 100MG | 1135 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 2279 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCisd2 agonist 1
-
NoteResearch use only, not for human use.
-
Brief DescriptionCisd2 agonist 1 is a potent CDGSH iron-sulfur structural domain 2 (CISD2) agonist (EC50: 34 nM) with potential anticancer activity for the study of non-alcoholic fatty liver disease (NAFLD).
-
DescriptionCisd2 agonist 1 (Compound 4q) is a Cisd2 agonist (EC50: 34 nM). Cisd2 agonist 1 enhances the Cisd2 expression and improves the pathological changes in the fatty livers. Cisd2 agonist 1 has good metabolic stability. Cisd2 agonist 1 can be used for research of NAFLD.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2916371-54-3
-
Formula Weight308.33
-
Molecular FormulaC14H13FN2O3S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (324.33 mM; Ultrasonic )
-
SMILESO=C(OC)C1=C(SC(C(=O)NC2=CC=C(F)C=C2)=C1C)N
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Yao CH, et al. Discovery of tetrasubstituted thiophenes as Cisd2 activators: A potential novel therapeutic option in nonalcoholic fatty liver disease. Eur J Med Chem. 2023 Oct 5;258:115583.?
molnova catalog
related products
-
HJ Inhibitor Peptide...
HJ Inhibitor Peptide 2
-
(Ala6,D-Trp8,L-alani...
(Ala6,D-Trp8,L-alaninol15)-Galanin (1-15)
-
hPL-IN-2
hPL-IN-2 is a potent, reversible and non-competitive inhibitor of Pancreatic lipase (IC50: 1.63 μM) that can be used to investigate obesity-related diseases.
